IBERE PHARMACEUTICALS
SEC Filing List
IBER CIK: 0001835205
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 15-12G | Notice of termination of registration of... | Toppan Merrill/FA | 03/13/2023 | ||
| 25-NSE | Notification filed by national security ... | NEW YORK STOCK EXCHANGE LLC /fa | 03/02/2023 | ||
| 8-K | Current report filing | Toppan Merrill/FA | 02/15/2023 | ||
| SC 13G/A | Amendment to Schedule filed to report ac... | Citadel Advisors Llc | Toppan Merrill/FA | 02/14/2023 | |
| SC 13G | Schedule filed to report acquisition of ... | Glazer Capital, Llc | GLAZER CAPITAL, LLC /fa | 02/14/2023 | |
| SC 13G | Schedule filed to report acquisition of ... | Hudson Bay Capital Management Lp | Hudson Bay Capital Management LP /fa | 02/08/2023 | |
| SC 13G/A | Amendment to Schedule filed to report ac... | Hartree Partners, Lp | WILLKIE FARR & GALLAGHER /fa | 02/08/2023 | |
| SC 13G/A | Amendment to Schedule filed to report ac... | Magnetar Financial Llc | Toppan Merrill/FA | 02/02/2023 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Toppan Merrill/FA2 | 11/14/2022 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Toppan Merrill/FA2 | 08/12/2022 | ||
| No record found. | |||||
| Load More | |||||
